New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 18, 2013
12:42 EDTCYNO, PMTICynosure acquisition positive, says Maxim
After Cynosure (CYNO) agreed to buy Palomar Medical (PMTI), Maxim thinks the deal will be positive over time for Cynosure, as it believes the deal should increase the company's revenue growth. The firm, however, warns that Cynosure's stock could drop in the short-term. Maxim maintains a Buy rating on Cynosure.
News For CYNO;PMTI From The Last 14 Days
Check below for free stories on CYNO;PMTI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2014
08:31 EDTCYNOCynosure appoints COO and CFO Timothy W. Baker as President
Subscribe for More Information
July 29, 2014
13:54 EDTCYNOCynosure Q2 concerns proved unfounded, says Maxim
Subscribe for More Information
08:03 EDTCYNOCynosure plans to focus on broadening reach
Subscribe for More Information
08:01 EDTCYNOCynosure reports Q2 non-GAAP EPS 32c, consensus 29c
Reports Q2 revenue $72.9M, consensus $71.15M.
July 24, 2014
08:35 EDTCYNOCynosure receives expanded FDA clearance to market Picosure
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use